Friday, September 3, 2010
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Peter Duncan
Director of Business Development
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Information Technology
1 of 3
Previous |
Next
Information Technology
Tailor-made solutions for preclinical efficacy research
Jussi Halleen and Rami Käkönen, Pharmatest Services Ltd
No Comments
MDS Pharma Services Helps to Fight Malaria
The CRO is managing a pivotal Phase III study involving more than 2500 malaria patients in Asia and Africa
No Comments
Moving from EDC to a complete eclinical trial solution
Competitive pressures are forcing the pharmaceutical and biotechnology industries to become more efficient when developing new products.
No Comments
Integrating Clinical Data
By John R. Schoenfelder, Ph.D., Dolores R. Massari, and Margaret E. Hurley, M.D.
No Comments
Speeding Time to Market and Ensuring Regulatory Compliance with Business Process and Content Management Integration
By Christopher Sprague.
As a life sciences company, your goal is to safely speed products to market while meeting your regulatory obligations.
No Comments
1 of 3
Previous |
Next
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.